Stockwinners Market Radar for January 26, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
SNE... | Hot Stocks19:50 EST Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. U.S. state attorneys general will meet Justice Department attorneys next week to share information on their investigations into Alphabet's (GOOG) Google, Reuters' Nandita Bose wrote, citing two sources familiar with the matter. The probes revolve around monopolistic behavior that may harm consumers through Google's control of online advertising markets and search traffic, the report noted. 2. Drugmaker AbbVie (ABBV) said that China is testing an HIV drug as a treatment for symptoms of the new coronavirus that is rapidly spreading, according to Reuters. China health authorities requested the drug to help with the government's efforts to address the crisis, according to Adelle Infante, a spokeswoman for AbbVie. Meanwhile, Starbucks (SBUX) has closed all shops and suspended delivery services in China's Hubei province for the week-long Lunar New Year holiday amid the new coronavirus outbreak, according to Reuters. Starbucks said that the move is out of "health concerns" for its customers and employees, the report noted. 3. Big tech companies, including Amazon (AMZN), Microsoft (MSFT), and Alphabet, are competing for a bigger slice of the esports live-streaming business, which could present an opportunity for investors, Connor Smith wrote in this week's edition of Barron's. Esports events-where the best players compete in games like League of Legends, Activision Blizzard's (ATVI) Overwatch, and Valve's Dota 2 and Counter-Strike: Global Offensive-are attracting young people, much the way traditional sports had for generations, the author noted. 4. Sony's (SNE) "Bad Boys for Life" won this weekend's domestic box office in its second outing, earning $34M to finish Sunday with a total of $120.6M. Worldwide, the movie crossed the $200M mark after grossing another $42M overseas from 58 markets for a foreign cume of $95M and $215.6M globally. "Bad Boys for Life" sports an A CinemaScore and a 76% Rotten Tomatoes rating. 5. HP Inc. (HPQ) saw a positive mention in this week's edition of Barron's, while Omnicom Group (OMC) and Interpublic Group (IPG) in the U.S., Publicis Groupe (PUBGY) in Paris, and WPP (WPP) were mentioned cautiously.
|
GOOGL GOOG | Hot Stocks16:29 EST State AGs, DOJ officials to meet, coordinate on Google probe, Reuters says - U.S. state attorneys general will meet Justice Department attorneys next week to share information on their investigations into Alphabet's Google, Reuters' Nandita Bose write, citing two sources familiar with the matter. The probes revolve around monopolistic behavior that may harm consumers through Google's control of online advertising markets and search traffic, the report notes. Reference Link
|
NH | Hot Stocks16:17 EST NantHealth GPS Cancer platform data reveals opportunities in colorectal cancer - NantHealth has announced Results of a fifty-gene breast cancer RNA subtype classifier applied to 167 colorectal cancer patients during a poster session at the 2020 Gastrointestinal Cancer Symposium sponsored by the American Society of Clinical Oncology. NantHealth's presentation utilized data on whole exome DNA tumor and paired germline and matched deep whole transcriptomic sequencing to identify a higher percentage of CRC patients with HER2 signaling than conventional methods of immunohistochemistry or fluorescence in-situ hybridization. ERBB2 gene expression was evaluated using NantOmics Nant50 gene classifier, which separates patients into subgroups that have been well established in breast cancer. The application of this tool to colorectal cancer proved surprising with greater than expected HER2 positive patients with a normally expected distribution of CMS classification. This finding suggests a possible utility for this tool in a new clinical setting. In addition, the HER2 enriched group did not show differentially expressed mutations in other targetable genes such as PIK3CA and BRAF, highlighting the potential importance of HER2 targeting in this population.
|
NH | Hot Stocks16:11 EST NantHealth announces real-world data on treatment patterns for patients with CRC - NantHealth has announced new real-world data on treatment patterns for patients with advanced colorectal cancer during a poster session at the 2020 Gastrointestinal Cancer Symposium sponsored by the American Society of Clinical Oncology. NantHealth's presentation examined therapeutic preferences and treatment patterns among advanced CRC patients using data from NantHealth's Eviti Connect, an evidence-based treatment intelligence and web-based oncology decision support platform. Detailed information from 6,325 treatment plans was analyzed to identify treatment patterns using regorafenib and trifluridine + tipiracil for advanced CRC patients as third-line of therapy. National Comprehensive Cancer Network guidelines state that regorafenib and trifluridine+tipiracil are both treatment options for patients who have progressed through all available regimens. Across all 6,325 treatment plans submitted for this patient population, regorafenib or trifluridine+tipiracil was the submitted treatment in 361 of the treatment plans, making them the 9th and 13th most frequently requested drugs in this setting. While the total number of treatment plans for regorafenib was higher than that for trifluridine+tipiracil, the submission of trifluridine+tipiracil has increased over time, consistent with the latter drug's more recent introduction into the market.
|
BA GE | Hot Stocks16:08 EST New Boeing 777X completes first flight - The new Boeing (BA) 777X jetliner took to the skies on Saturday, entering the next phase of its test program. Based on the 777 and with proven technologies from the 787 Dreamliner, the 777X took off in front of thousands at Paine Field in Everett, Washington, at 10:09 a.m. local time for a three-hour, 51-minute flight over Washington state before landing at Seattle's Boeing Field. The first of four dedicated 777-9 flight test airplanes, WH001 will now undergo checks before resuming testing in the coming days. The test fleet, which began ground testing in Everett last year, will endure a comprehensive series of tests and conditions on the ground and in the air over the coming months to demonstrate the safety and reliability of the design. The newest member of Boeing's market-leading widebody family, the 777X will deliver 10% lower fuel use and emissions and 10% lower operating costs than the competition through advanced aerodynamics, the latest generation carbon-fiber composite wing and the most advanced commercial engine ever built, GE (GE) Aviation's GE9X. Boeing expects to deliver the first 777X in 2021. The program has won 340 orders and commitments from carriers around the world, including ANA, British Airways, Cathay Pacific Airways, Emirates, Etihad Airways, Lufthansa, Qatar Airways and Singapore Airlines.
|